Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | CDK1 | P06493 | 1/20 | 0.55 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4527554 | 1.00 | GAA (0.58) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL18650671 | 1.00 | GAA (0.58) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL17254874 | 1.00 | GAA (0.58) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL20050054 | 1.00 | GAA (0.58) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL18654187 | 1.00 | GAA (0.58) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL25142231 | 1.00 | GAA (0.58) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL18650646 | 1.00 | GAA (0.58) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL4275427 | 1.00 | GAA (0.58) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL4404793 | 1.00 | GAA (0.58) | GAACDK1CCNB1ACHEL3MBTL1 | |
| SCHEMBL18650637 | 1.00 | GAA (0.58) | GAACDK1CCNB1ACHEL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3398606-B1 | MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN | ALGENIST HOLDINGS INC (US) | 2021-09-15 | — | — | EP | disclosed |
| US-20180353393-A1 | MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN | ALGENIST HOLDINGS, INC. (US) | 2018-12-13 | — | — | US | disclosed |
| EP-3398606-A1 | MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN | TerraVia Holdings, Inc. (US) | 2018-11-07 | — | — | EP | disclosed |
| US-9993399-B2 | Microalgae-derived compositions for improving the health and appearance of skin | ALGENIST HOLDINGS, INC. (US) | 2018-06-12 | — | — | US | disclosed |
| EP-1986665-B1 | MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN | TERRAVIA HOLDINGS INC (US) | 2018-05-02 | — | — | EP | disclosed |
| US-20150140051-A1 | Microalgae-Derived Compositions for Improving the Health and Appearance of Skin | ALGENIST BRANDS LLC | 2015-05-21 | — | — | US | disclosed |
| US-8956852-B2 | Heterotrophic cultivation of hydrocarbon-producing microalgae | SOLAZYME, INC. (US) | 2015-02-17 | — | — | US | disclosed |
| US-8932652-B2 | Microalgae-derived compositions for improving the health and appearance of skin | SOLAZYME, INC. (US) | 2015-01-13 | — | — | US | disclosed |
| US-20130071909-A1 | Heterotrophic Cultivation of Hydrocarbon-Producing Microalgae | SOLAZYME, INC. (US) | 2013-03-21 | — | — | US | disclosed |
| US-20130004554-A1 | Microalgae-Derived Compositions for Improving the Health and Appearance of Skin | SOLAZYME, INC. (US) | 2013-01-03 | — | — | US | disclosed |
| CN-101243074-A | Heterocyclic compounds | JAPAN TOBACCO INC (JP) | 2008-08-13 | — | — | CN | disclosed |
| US-20070191303-A1 | Polysaccharide compositions and methods of producing, screening, and formulating polysaccharide compositions | SOLAZYME, INC. (US) | 2007-08-16 | — | — | US | disclosed |
| US-20070166449-A1 | Methods and compositions for thickening, stabilizing and emulsifying foods | SOLAZYME, INC. (US) | 2007-07-19 | — | — | US | disclosed |
| US-20070167398-A1 | Methods and compositions for reducing inflammation and preventing oxidative damage | SOLAZYME, INC. (US) | 2007-07-19 | — | — | US | disclosed |
| US-20070167397-A1 | Methods and compositions for joint lubrication | SOLAZYME, INC. (US) | 2007-07-19 | — | — | US | disclosed |
| US-20070167396-A1 | Methods and compositions for cholesterol reduction in mammals | SOLAZYME, INC. (US) | 2007-07-19 | — | — | US | disclosed |
| US-20070166797-A1 | Devices and solutions for prevention of sexually transmitted diseases | SOLAZYME, INC. (US) | 2007-07-19 | — | — | US | disclosed |
| US-20070166266-A1 | Methods and compositions for improving the health and appearance of skin | SOLAZYME, INC. (US) | 2007-07-19 | — | — | US | disclosed |
| EP-0013742-B1 | SUBSTITUTED SULFONIC ACID ANILIDES, THEIR PREPARATION AND USE | BASF Aktiengesellschaft (DE) | 1982-12-22 | — | — | EP | disclosed |
| EP-0013742-A1 | Substituted sulfonic acid anilides, their preparation and use | BASF Aktiengesellschaft (DE) | 1980-08-06 | — | — | EP | disclosed |